Immunologic barriers to hepatic adenoviral gene therapy for transplantation: Cellular and humoral responses limit transgene expression in mouse liver

Transplantation

Volumn 63, Issue 2, 1997, Pages 315-319

  DeMatteo, Ronald P ^a,b   Chu, Gorden ^a   Ahn, Max ^a   Chang, Eddie ^a   Burke, Charlotte ^a   Raper, Steve E ^a   Barker, Clyde F ^a   Markmann, James F ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; NEUTRALIZING ANTIBODY;

ADENOVIRUS; ALLOGRAFT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; GENE THERAPY; GENE TRANSFER; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; LIVER TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS RECOMBINANT;

ADENOVIRIDAE; ALKALINE PHOSPHATASE; ANIMALS; ANTIBODY FORMATION; B-LYMPHOCYTES; BETA-GALACTOSIDASE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; GENE THERAPY; IMMUNITY, CELLULAR; IMMUNOLOGIC DEFICIENCY SYNDROMES; LIVER; LIVER TRANSPLANTATION; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICE, NUDE; MICE, SCID; MICE, TRANSGENIC; RECOMBINANT PROTEINS; SPECIES SPECIFICITY; T-LYMPHOCYTES;

EID: 0030899366     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199701270-00024     Document Type: Article

References (14)

1. Rosengard AM, Cary NR, Langford GA, Tucker AW, Wallwork J, White DJ. Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs: a potential approach for preventing xenograft rejection. Transplantation 1995; 59: 1325.
2. Crystal RG. Transfer of genes to humans: early lessons and obstacles to success. Science 1995; 270: 404.
3. Fisher KJ, Gao GP, Weitzman M, DeMatteo RP, Burda JF, Wilson JM. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading strand synthesis. J Virol 1996; 70: 520.
4. Crystal RG, McElvaney NG, Rosenfeld MA, et al. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genetics 1994; 8: 42.
5. Yang Y, Nunes F, Berencsi K, Furth EE, Gonczol E, Wilson JM. Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994; 91: 4407.
6. Kitamura D, Roes J, Kuhn R, Rajewsky K. A B cell deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 1991; 350: 423.
7. Koller BH, Marrack P, Kappler JW, Smithies O. Normal development of mice deficient in beta2M, MHC class I proteins, and CD8+ T cells. Science 1990; 248: 1227.
8. Grusby MJ, Johnson RS, Papaioannou VE, Glimcher LH. Deletion of CD4+ T cells in major histocompatibility complex class II deficient mice. Science 1991; 253: 1417.
9. Yang Y, Nunes F, Berencsi K, Gonczol E, Engelhardt JF, Wilson JM. Inactivation of E2A in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nature Genetics 1994; 7: 362.
10. DeMatteo RP, Raper SE, Ahn M, et al. Gene transfer to the thymus: a means of abrogating the immune response to recombinant adenovirus. Ann Surg 1995; 222: 229.
11. DeMatteo RP, Markmann JF, Kozarsky KF, Barker CF, Raper SE. Prolongation of adenoviral transgene expression in mouse liver by T lymphocyte subset depletion. Gene Therapy 1996; 3: 4.
12. Yang Y, Ertl HCJ, Wilson JM. MHC class-1 restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1994; 1: 433.
13. Epstein MM, DiRosa F, Jankovic D, Sher A, Matzinger P. Successful T cell priming in B cell-deficient mice. J Exp Med 1995; 182: 915.
14. Tripathy SK, Black HB, Goldwasser E, Leiden JM. Immune responses to transgene-encoded proteins limits the stability of gene expression after injection of replication-defective adenovirus vectors. Nature Medicine 1996; 2: 545.